Lovaza
Pricing Report NDC 69784-420-12
View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Current Package Pricing Information
This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.
The latest wholesale acquisition cost for Lovaza (NDC 69784-420-12) is $8.07699 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 27, 2024.
As a provided by Woodward Pharma Services Llc, this medication is distributed in a 120 CAPSULE, LIQUID FILLED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $8.07699 Per EA
Pricing Unit
Effective Date
Nov 27, 2024
Billable Units
120 EA
Estimated Package Price
$969.24
Data Status
As of Apr 02, 2025
Generic Benchmark
The generic equivalent rate is
$0.17824
(Effective:
Mar 19, 2025)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Historical Pricing Trends & Acquisition Cost Benchmarks
Since May 2021, the NADAC wholesale price for (NDC ) has moved within a range of $2.74451 to $8.07699 per EA. Over this 3 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
Price Range
$2.7445 - $8.0770
$2.7445 - $8.0770
Market Volatility
194.30% Variance
194.30% Variance
Latest Trend
9.00%
9.00%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Nov 27, 2024 | $8.07699 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 27, 2024 | $8.07699 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 27, 2024 | $8.07699 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 27, 2024 | $8.07699 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 27, 2024 | $8.07699 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Nov 20, 2024 | $7.41008 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 23, 2024 | $7.40865 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Sep 18, 2024 | $7.41266 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 21, 2024 | $7.40338 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 17, 2024 | $7.40338 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jul 17, 2024 | $7.40338 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jun 19, 2024 | $7.39857 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jun 19, 2024 | $7.39857 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| May 22, 2024 | $7.39837 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 17, 2024 | $7.49158 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 17, 2024 | $7.49158 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 17, 2024 | $7.49158 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Jan 17, 2024 | $7.49158 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Mar 30, 2023 | $6.51441 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 02, 2022 | $5.93276 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 02, 2022 | $5.93276 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 02, 2022 | $5.93276 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 02, 2022 | $5.93276 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Dec 02, 2022 | $5.93276 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 04, 2022 | $5.40566 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| May 04, 2022 | $5.40566 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| May 04, 2022 | $5.40566 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 04, 2022 | $5.40566 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 04, 2022 | $5.40566 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 04, 2022 | $5.40566 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 04, 2022 | $5.40566 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 04, 2022 | $5.40566 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 01, 2021 | $3.19816 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 01, 2021 | $3.19816 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 01, 2021 | $3.19816 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 01, 2021 | $3.19816 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 01, 2021 | $3.19816 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 01, 2021 | $3.19816 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 01, 2021 | $3.19816 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Oct 01, 2021 | $3.19816 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 18, 2021 | $2.78098 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 18, 2021 | $2.78098 | EA | C/I - Chain or Independent Pharmacy | Code 1, 6 | B-ANDA - Abbreviated New Drug Application |
| Aug 18, 2021 | $2.78098 | EA | C/I - Chain or Independent Pharmacy | Code 2, 6 | B-ANDA - Abbreviated New Drug Application |
| May 26, 2021 | $2.74451 | EA | C/I - Chain or Independent Pharmacy | Code 3, 6 | B-ANDA - Abbreviated New Drug Application |
| May 26, 2021 | $2.74451 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
| May 26, 2021 | $2.74451 | EA | C/I - Chain or Independent Pharmacy | Code 4, 6 | B-ANDA - Abbreviated New Drug Application |
Pricing Methodology Legend
- Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
- Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
- Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
